472 related articles for article (PubMed ID: 12168863)
21. The TLR2 agonist in polysaccharide-K is a structurally distinct lipid which acts synergistically with the protein-bound β-glucan.
Quayle K; Coy C; Standish L; Lu H
J Nat Med; 2015 Apr; 69(2):198-208. PubMed ID: 25510899
[TBL] [Abstract][Full Text] [Related]
22. Effect of Krestin (PSK) on the induction of IL-2 activated killer cells.
Sakamaki S; Kohgo Y; Nojiri S; Kanisawa Y; Ito Y; Takahashi M; Ueno Y; Hirayama Y; Niitsu Y
Jpn J Clin Oncol; 1992 Apr; 22(2):79-83. PubMed ID: 1619782
[TBL] [Abstract][Full Text] [Related]
23. PSK immunotherapy in cancer patients--a preliminary report.
Chung CH; Go P; Chang KH
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):210-6. PubMed ID: 3322700
[TBL] [Abstract][Full Text] [Related]
24. Restoration of immune responsiveness by a biological response modifier, PSK, in aged mice bearing syngeneic transplantable tumor.
Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
J Clin Lab Immunol; 1987 Nov; 24(3):143-9. PubMed ID: 3430562
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K.
Yefenof E; Gafanovitch I; Oron E; Bar M; Klein E
Cancer Immunol Immunother; 1995 Dec; 41(6):389-96. PubMed ID: 8635197
[TBL] [Abstract][Full Text] [Related]
26. Protein-bound polysaccharide K induced apoptosis of the human Burkitt lymphoma cell line, Namalwa.
Hattori TS; Komatsu N; Shichijo S; Itoh K
Biomed Pharmacother; 2004 May; 58(4):226-30. PubMed ID: 15183847
[TBL] [Abstract][Full Text] [Related]
27. [Clinical effects of PSK on esophageal and gastric cancer patients and usefulness of serum levels of glycoproteins and HLA antigens as prognostic indicators].
Ogoshi K; Mitomi T
Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1443-6. PubMed ID: 2586437
[TBL] [Abstract][Full Text] [Related]
28. Protein-bound polysaccharide-K (PSK) induces apoptosis and inhibits proliferation of promyelomonocytic leukemia HL-60 cells.
Hirahara N; Fujioka M; Edamatsu T; Fujieda A; Sekine F; Wada T; Tanaka T
Anticancer Res; 2011 Sep; 31(9):2733-8. PubMed ID: 21868514
[TBL] [Abstract][Full Text] [Related]
29. Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones.
Algarra I; Collado A; Garrido F
J Exp Clin Cancer Res; 1997 Dec; 16(4):373-80. PubMed ID: 9505208
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker.
Kudo S; Tanaka J; Kashida H; Tamegai Y; Endo S; Yamano HO
Oncol Rep; 2002; 9(3):635-8. PubMed ID: 11956642
[TBL] [Abstract][Full Text] [Related]
31. Protein-bound polysaccharide-K augments the anticancer effect of fluoropyrimidine derivatives possibly by lowering dihydropyrimidine dehydrogenase expression in gastrointestinal cancers.
Mekata E; Murata S; Sonoda H; Shimizu T; Umeda T; Shiomi H; Naka S; Yamamoto H; Abe H; Edamatsu T; Fujieda A; Fujioka M; Wada T; Tani T
Oncol Rep; 2013 Dec; 30(6):2845-51. PubMed ID: 24100378
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of polysaccharopeptide effects against C6 glioma in combination with radiation.
Mao XW; Green LM; Gridley DS
Oncology; 2001; 61(3):243-53. PubMed ID: 11574781
[TBL] [Abstract][Full Text] [Related]
33. The use of mushroom glucans and proteoglycans in cancer treatment.
Kidd PM
Altern Med Rev; 2000 Feb; 5(1):4-27. PubMed ID: 10696116
[TBL] [Abstract][Full Text] [Related]
34. [Restoration of depressed immune responses by PSK in C3H/He mice bearing the syngeneic X5563 tumor].
Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3453-60. PubMed ID: 3789756
[TBL] [Abstract][Full Text] [Related]
35. [Immunomodulatory and antitumor properties of polysaccharide peptide (PSP)].
Piotrowski J; Jędrzejewski T; Kozak W
Postepy Hig Med Dosw (Online); 2015 Jan; 69():91-7. PubMed ID: 25614677
[TBL] [Abstract][Full Text] [Related]
36. [Effect of PSK on recurrence of stage II/III gastric cancer].
Tanaka H; Muguruma K; Kubo N; Amano R; Noda E; Yamada N; Yashiro M; Maeda K; Sawada T; Ohira M; Ishikawa T; Hirakawa K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2258-60. PubMed ID: 21224540
[TBL] [Abstract][Full Text] [Related]
37. [Compound therapy including PSK for malignant head and neck cancer].
Hoshiya T; Matsunaga T; Hyo Y; Mori N; Kakiuchi H; Saeki K; Wakuda K
Gan To Kagaku Ryoho; 1982 Jan; 9(1):91-5. PubMed ID: 7184365
[TBL] [Abstract][Full Text] [Related]
38. Immunotherapy for esophageal cancer. A randomized trial in combination with radiotherapy and radiochemotherapy. Cooperative Study Group for Esophageal Cancer in Japan.
Ogoshi K; Satou H; Isono K; Mitomi T; Endoh M; Sugita M
Am J Clin Oncol; 1995 Jun; 18(3):216-22. PubMed ID: 7747709
[TBL] [Abstract][Full Text] [Related]
39. Polysaccharide K induces Mn superoxide dismutase (Mn-SOD) in tumor tissues and inhibits malignant progression of QR-32 tumor cells: possible roles of interferon alpha, tumor necrosis factor alpha and transforming growth factor beta in Mn-SOD induction by polysaccharide K.
Habelhah H; Okada F; Nakai K; Choi SK; Hamada J; Kobayashi M; Hosokawa M
Cancer Immunol Immunother; 1998 Aug; 46(6):338-44. PubMed ID: 9756418
[TBL] [Abstract][Full Text] [Related]
40. Polysaccharide Krestin enhances manganese superoxide dismutase activity and mRNA expression in mouse peritoneal macrophages.
Pang ZJ; Chen Y; Zhou M
Am J Chin Med; 2000; 28(3-4):331-41. PubMed ID: 11154046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
